Diabetes PubMed

  • Increase font size
  • Default font size
  • Decrease font size
Home Medication Experimental agents Hypoglycemic polysaccharides from the tuberous root of Liriope spicata

Hypoglycemic polysaccharides from the tuberous root of Liriope spicata

J Nat Prod. 2009 Nov;72(11):1988-92.

Chen X, Liu Y, Bai X, Wen L, Fang J, Ye M, Chen J.

Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, Tongji School of Pharmaceutical Sciences, Huazhong University of Science and Technology, Hangkong Road 13#, Wuhan 430030, People's Republic of China.

Previous studies showed that the water extract and crude polysaccharides from the tuberous root of Liriope spicata var. prolifera showed high hypoglycemic and hypolipidemic activities. In the present study, two new water-soluble polysaccharides, named LSP1 and LSP2, were isolated from the active crude polysaccharides by DEAE-cellulose 52 and AB-8 macroporous resin chromatography and tested for their hypoglycemic effects. On the basis of the chemical and physical data obtained, LSP1 and LSP2 are two fructans with the molecular weights 3.20 and 4.29 kDa, respectively, which both have a backbone structure of beta-(1-->2)-fructosyl residues that branches at O-6 with fructosyl residues and terminates with a glucosyl residue and a fructosyl residue. Preliminary activity tests revealed that both LSP1 and LSP2 caused a significant decrease of the fasting blood glucose (FBG) and a significant improvement on glucose tolerance in type 2 diabetic mice. These results suggest that LSP1 and LSP2 show high potential to be explored as natural oral hypoglycemic agents.

PMID: 19874043

 

Bookmark and Share

Popular Diabetes PubMed Citations

Newsflash

Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.
 
Bristol-Myers Squibb Foundation Launches $100 Million Initiative
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office - in their homes and communities - and for the course of their disease.
 
New global survey reveals more than one in three patients fail to take insulin as prescribed
More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77% of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM) survey, released today by Novo Nordisk.
 

Facebook Page Twitter Subscribe to Latest Diabetes PubMed facts... by Email RSS

Subscribe

Get Diabetes PubMed facts delivered by email. Enter your email address:


Delivered by FeedBurner

Who's Online

We have 8 guests online

Sponsored Links

PharmaNews.eu
PharmaNews.eu - the dynamic European pharmaceutical news engine.
www.pharmanews.eu

Advertise here